Report - 761121Orig1s000 - accessdata.fda.gov · receptors (IIA allotypes R131 and H131, IIB, or IIIA allotypes F158 and V158). In cell-based assays, polatuzumab vedotin antibody-dependent

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form